Drug Resistant Epilepsy

Drug-resistant epilepsy, also known as refractory or pharmacoresistant epilepsy, is defined as failure of adequate trials of two appropriate and tolerated antiepileptic drugs (as monotherapies or in combination) to achieve sustained seizure freedom. Discover the latest research on drug-resistant epilepsy here.

July 24, 2020

Pediatric to Adult Transitions of Ketogenic Dietary Therapy for Epilepsy

Journal of Child Neurology
Kristin SeaborgElizabeth A Felton
July 28, 2020

Real-world hospitalization risk in patients with epilepsy treated with perampanel

Epilepsy & Behavior : E&B
Xuan LiMugdha Gore
July 28, 2020
Preprint
Open Access

Effects of constitutive and acute Connexin 36 deficiency on brain-wide susceptibility to PTZ-induced neuronal hyperactivity

BioRxiv : the Preprint Server for Biology
A. A. BrunalY. Albert Pan
July 31, 2020
Review

Vigabatrin add-on therapy for drug-resistant focal epilepsy

The Cochrane Database of Systematic Reviews
Rebecca BresnahanAnthony G Marson
July 23, 2020
Clinical Trial
Open Access

An intensive education program for caregivers ameliorates anxiety, depression, and quality of life in patients with drug-resistant temporal lobe epilepsy and mesial temporal sclerosis who underwent cortico-amygdalohippocampectomy

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Yuena WangMeiling Sun
August 1, 2020
Preprint

Data-driven method to infer the seizure propagation patterns in an epileptic brain from intracranial electroencephalography

MedRxiv : the Preprint Server for Health Sciences
V. SipViktor K Jirsa
August 1, 2020

Epilepsy surgery in neurofibromatosis type 1: an overlooked therapeutic approach

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Pia BernardoGiuseppe Cinalli
August 1, 2020
Open Access

Ketogenic Diet Provided During Three Months Increases KCC2 Expression but Not NKCC1 in the Rat Dentate Gyrus

Frontiers in Neuroscience
Leticia Granados-RojasPilar Durán
July 31, 2020

Trends in the use of automated algorithms for the detection of high-frequency oscillations associated with human epilepsy

Epilepsia
Kavyakantha Remakanthakurup SindhuBeth A Lopour
July 31, 2020

Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications

The Clinical Neuropsychologist
Kristine StadskleivPetter Brandal
July 24, 2020

Changes of EEG spectra in rat brains with different patterns of dysplasia in response to pilocarpine-induced seizures

Epilepsy & Behavior : E&B
Zuzanna SetkowiczKrzysztof Janeczko
July 28, 2020

Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?

Brain & Development
Shimrit Uliel-SibonyUri Kramer

Sign up to follow this feed and discover related papers.

Related Feeds

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Benign Rolandic Epilepsy

Benign Rolandic epilepsy is a partial idiopathic epilepsy of childhood presenting with a nocturnal seizure and with a typical EEG showing centrotemporal spike and multifocal or generalized sharp slow waves. Here is the latest research.

Dravet Syndrome

Dravet syndrome, previously known as severe myoclonic epilepsy of infancy (SMEI), is a rare, catastrophic, lifelong form of epilepsy with frequent and/or prolonged seizures that are often triggered by hot temperatures or fever. Discover the latest research on Dravet syndrome here.

Early Myoclonic Encephalopathy

Early myoclonic encephalopathy is an epileptic syndrome typically diagnosed by three months of age. It is characterized by frequent seizures and severe early encephalopathy and has a severely reduced life expectancy. Causes can include metabolic abnormalities or genetic mutations. Find the latest research on early myoclonic encephalopathy here.

Epilepsy

Epilepsy is a chronic neurological disorder characterized by unprovoked and recurrent seizures. Discover the latest research on factors and mechanisms that underlie epilepsy here.

Frontal Lobe Epilepsy

Frontal lobe epilepsy is characterized by brief, recurring seizures, often during sleep. Depending on the areas of the brain that are affected, these seizures may be asymptomatic or present with motor or verbal symptoms. Find the latest research on frontal lobe epilepsy here.

Juvenile Myoclonic Epilepsy

Juvenile myoclonic epilepsy, previously known as idiopathic generalized epilepsy, is a form of generalized epilepsy whose cause is presumed to be genetic in origin. The first seizure typically occurs between the ages of 5-12, and symptoms may improve after the fourth decade of life. Seizure may be of different subtypes, including absence, myoclonic, and tonic-clonic. Find the latest research on juvenile myoclinic epilepsy here.

Lafora Disease

Lafora disease is an inherited neurodegenerative disorder characterized by the presence of abnormal glycogen inclusions, called Lafora bodies, in neurons and other tissues. Here is the latest research on this fatal, autosomal recessive disorder.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

© 2020 Meta ULC. All rights reserved
/feed-previews/drug-resistant-epilepsy/4ba445ca-9604-4931-8f4c-ac6a91fbd48b